Scientific Sessions 2025  /  AF Lifestyle Therapy: Drugs Beyond Heart Failure and Obesity  /  SGLT2 inhibitors: the new antiarrhythmic around the block?
Logo

American Heart Association

  33
  0

Final ID:

SGLT2 inhibitors: the new antiarrhythmic around the block?

  • Patel, Siddharth  ( Brigham and Womens Hospital , Boston , Massachusetts , United States )
  • Wiviott, Stephen  ( Brigham and Womens Hospital , Boston , Massachusetts , United States )
    • Author Disclosures:
    Siddharth Patel: DO have relevant financial relationships ; Consultant:Janssen:Active (exists now) | Stephen Wiviott: DO have relevant financial relationships ; Researcher:Amgen, AstraZeneca,Janssen, Merck , Pfizer:Past (completed) ; Speaker:Honoraria for speaking, Harvard Medical school:Past (completed) ; Other (please indicate in the box next to the company name):Spouse is a current employee of Pfizer and former employee of Flagship labs, and Vertex:Active (exists now) ; Consultant:Icon, Novo Nordisk, Varian:Past (completed)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

AF Lifestyle Therapy: Drugs Beyond Heart Failure and Obesity

Friday, 11/07/2025 , 12:30PM - 01:45PM

Cardiovascular Seminar

More abstracts on this topic:
Modifiable risk factors for atrial fibrillation

Albert Christine, Sanders Prashanthan

Atrial Fibrosis progression in sleep apnea patients: A pilot study (PROOF Study)

Marrouche Nassir

More abstracts from these authors:
Contemporary Practice Patterns of Vasoactive Agents in Cardiogenic Shock: An Analysis of the AHA Cardiogenic Shock Registry

Patel Siddharth, Berg David, Bohula Erin, Palazzolo Michael, Krucoff Mitchell, Morrow David

Panel Discussion

Wiviott Stephen

You have to be authorized to contact abstract author. Please, Login
Not Available